Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook
William Guyer's pre-scheduled disposition under a Rule 10b5-1 plan liquidates some direct holdings while retaining 130,000 derivative securities.
Read the full articleYou might also wanna read
Insider Sell Alert: Todd Duchene Sells 10,000 Shares of Core Scientific Inc (CORZ)
Related Stocks: CORZ
GuruFocus·1d ago
Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA
Related Stocks: SOPH
GuruFocus·2d ago
Corcept Therapeutics Inc (NASDAQ:CORT) Shows Strong Growth Fundamentals and Technical Breakout Setup
Corcept Therapeutics (CORT) shows strong growth with 12.2% revenue growth, zero debt, and accelerating EPS forecasts. The stock is near a 52
ChartMill·5d ago
Insider Sell: Meredith Cook Sells 500 Shares of ANI Pharmaceuticals Inc (ANIP)
Related Stocks: ANIP
GuruFocus·2d ago
Indivior Pharmaceuticals Inc (INDV) Insider Sell: Christian Heidbreder Sells 18,586 Shares
Related Stocks: INDV
GuruFocus·3d ago
Insider Sell: Saqib Baig Sells 5,000 Shares of Peloton Interactive Inc (PTON)
Related Stocks: PTON
GuruFocus·7h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.